Pneumotox » Drug » Anticoagulants, oral (vitamin K antagonists-VKA) » III.a - Alveolar hemorrhage (AH), diffuse AH (DAH)

Anticoagulants, oral (vitamin K antagonists-VKA)

5

III.a Alveolar hemorrhage (AH), diffuse AH (DAH)

2

Last update : 16/08/2012

Diagnosing DIRD

1

Drug and radiation history

2

Drug singularity - Correct identification of the drug

3

Consistent timing of exposure v. onset of symptoms

4

Clinical, imaging, BAL, pathological pattern consistent with the specific drug

5

Careful exlusion of another cause

6

Remission of symptoms with removal of drug

7

Recurrence with rechallenge (rarely advisable)

8

Causality assessment

More detailed checklist

Publications